Drug Discovery

share

Sanofi Genzyme and Principia Biopharma have entered into a license agreement to advance the clinical development of PRN2246, an...

share

Sanofi has signed a licence agreement to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246), which is...

share

Takeda Pharmaceutical Company Limited and HemoShear Therapeutics announced a partnership to discover and develop novel therapeutics for liver...

share

Transgene and Randox have entered into a collaboration to combine their technologies and develop multifunctional oncolytic immunotherapies. Innovative oncolytic...

share

Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to...

share

The Government of Australia announced new funding of $100m to advance brain cancer research as part of efforts...

share

A new study funded by the National Institutes of Health (NIH) in the US identified two proteins required...

3 shares

Labcyte Inc. announced that GSK has joined its consortium with AstraZeneca to combine acoustic liquid dispensing technology from...